Claims for Patent: 7,732,660

Summary for Patent: 7,732,660

Title:	Methods and means for producing efficient silencing construct using recombinational cloning
Abstract:	Methods and vectors and kits are provided for producing chimeric nucleic acid constructs capable of producing dsRNA for silencing target nucleic acid sequences of interest using recombinational cloning.
Inventor(s):	Helliwell; Christopher A. (Canberra, AU), Wesley; Susan V. (Ongole, IN), Waterhouse; Peter M. (Newtown, AU)
Assignee:	Commonwealth Scientific and Industrial Research Corporation (Campbell, AU)
Application Number:	11/034,069
Patent Claims:	1. A method for preparing a plant comprising a final chimeric DNA construct, said method comprising: preparing a final chimeric DNA construct capable of expressing a dsRNA of interest in a plant cell; said final chimeric DNA construct of interest comprising a DNA of interest (12) comprising a nucleotide sequence encoding said dsRNA of interest according to a method comprising the steps of combining in vitro a vector, an insert DNA and at least one site specific recombinase protein, said vector comprising the following operably linked DNA fragments: an origin of replication allowing replication in a recipient cell (1), a selectable marker region (2) capable of being expressed in said recipient cell; and a first chimeric DNA construct comprising in sequence: a promoter or promoter region (3) capable of being recognized by RNA polymerases of a plant cell; a first recombination site (4), a second recombination site (5), a third recombination site (6) and a fourth recombination site (7); a 3' transcription terminating and polyadenylation region (8) functional in said plant cell; wherein said first recombination site (4) and said fourth recombination site (7) are capable of reacting with a same recombination site, and said second recombination site (5) and said third recombination site (6), are capable of reacting with a same recombination site; and wherein said first recombination site (4) and said second recombination site (5) do not recombine with each other or with a same recombination site; or said third recombination site (6) and said fourth recombination site (7) do not recombine with each other or with a same recombination site; said insert DNA comprising said DNA segment of interest (12) flanked by a fifth recombination site (13) which is capable of recombining with said first (4) or fourth (7) recombination site on said vector; and a sixth recombination site (14) which is capable of recombining with said second (5) or third (6) recombination site on said vector; said at least one site specific recombination protein being capable of recombining said first (4) or fourth (7) and said fifth (13) recombination site and said second (5) or third (6) and said sixth (14) recombination site; allowing recombination to occur so as to produce a reaction mixture comprising product DNA molecules, said product DNA molecule comprising in sequence: said promoter or promoter region (3) capable of being recognized by RNA polymerases of said plant cell; a recombination site (15) which is the recombination product of said first (4) and said fifth (13) recombination site; said DNA fragment of interest (12); a recombination site (16) which is the recombination product of said second (4) and said sixth (14) recombination site; a recombination site (17) which is the recombination product of said third (5) and said sixth (14) recombination site; said DNA fragment of interest in opposite orientation (12); a recombination site (18) which is the recombination product of said fourth (7) and said fifth (13) recombination site; and said 3' transcription terminating and polyadenylation region (8) functional in said plant cell; selecting said product DNA molecules comprising said final chimeric DNA construct; and introducing said final chimeric DNA construct into at least one cell of said plant thereby preparing a plant comprising said final chimeric DNA construct. 2. A plant obtained through the method of claim 1. 3. The method according to claim 1, wherein said first (4) and second recombination site (5) flank a second selectable marker gene (10) and said third (6) and fourth recombination site (7) flank a third selectable marker gene (9). 4. The method according to claim 1 wherein said first chimeric DNA construct comprises a region flanked by intron processing signals (11), functional in said plant cell, located between said second recombination site (5) and said third recombination site (6). 5. The method according to claim 4 wherein said region flanked by intron processing signals is an intron sequence functional in said plant cell. 6. The method according to claim 4 wherein said vector further comprises a fourth selectable marker gene (19), located between said second (5) and third (6) rccombination site. 7. The method according to claim 1, wherein said vector comprises a selectable marker gene selected from the group consisting of an antibiotic resistance gene, a tRNA gene, an auxotrophic marker, a toxic gene, a phenotypic marker, an antisense oligonucleotide; a restriction endonuclease; a restriction endonuclease cleavage site, an enzyme cleavage site, a protein binding site, an a sequence complementary PCR primer. 8. The method according to claim 1, wherein said wherein said promoter (3) of said vector is a plant-expressible promoter. 9. The method according to claim 1, wherein said first chimeric DNA construct is flanked by left and right border T-DNA sequences. 10. The method according to claim 1 wherein said vector further comprises a selectable marker gene capable of being expressed in plant cells located between said left and said right T-DNA border sequences. 11. The method according to claim 1, wherein said vector of claim 8, further comprises an origin of replication capable of functioning in Agrobacterium sp. 12. The method according to claim 1, wherein said first (4) and fourth (7) recombination site is attR1 comprising the nucleotide sequence of SEQ ID No 4 and said second (5) and third (6) recombination site is attR2 comprising the nucleotide sequence of SEQ ID No 5. 13. The method according to claim 1, wherein said first (4) and fourth (7) recombination site is attP1 comprising the nucleotide sequence of SEQ ID No 10 and said second (5) and third (6) recombination site is attP2 comprising the nucleotide sequence of SEQ ID No 11. 14. The method according to claim 1, wherein said vector comprises the sequence of SEQ ID No 13. 15. The method according to claim 1, wherein said vector comprises the sequence of SEQ ID No 23. 16. The method according to claim 1, wherein said vector comprises the sequence of SEQ ID No 24. 17. The method according to claim 1, wherein said vector comprises the sequence of SEQ ID No 25. 18. The method according to claim 1, wherein said vector comprises the sequence of SEQ ID No 26. 19. The method according to claim 1, wherein said insert DNA is a linear DNA molecule. 20. The method according to claim 1, wherein said insert DNA is a circular DNA molecule. 21. The method according to claim 1, wherein said at least one recombination protein is selected from (i) Int (.lamda. integrase) and IHF (integration host factor) and (ii) Int, Xis (.lamda. excisionase), and IHF.

Details for Patent 7,732,660

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-03-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-03-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-03-29